Literature DB >> 26687674

Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al.

Richard A Bond1, Vaidehi J Thanawala1,2, Sergio Parra3, Paul Leff4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26687674      PMCID： PMC4813386          DOI： 10.1111/bph.13334

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  10 in total

Review 1.  New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.

Authors:  J K L Walker; R B Penn; N A Hanania; B F Dickey; R A Bond
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

2.  From mouse to man: predicting biased effects of beta-blockers in asthma.

Authors:  B J Lipworth; W J Anderson; P M Short
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739

3.  Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al.

Authors:  Richard A Bond; Vaidehi J Thanawala; Sergio Parra; Paul Leff
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739

4.  The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.

Authors:  Nicola A Hanania; Supria Singh; Rami El-Wali; Michael Flashner; Amie E Franklin; William J Garner; Burton F Dickey; Sergio Parra; Stephen Ruoss; Felix Shardonofsky; Brian J O'Connor; Clive Page; Richard A Bond
Journal:  Pulm Pharmacol Ther       Date:  2007-07-17       Impact factor: 3.410

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.

Authors:  James W Wisler; Scott M DeWire; Erin J Whalen; Jonathan D Violin; Matthew T Drake; Seungkirl Ahn; Sudha K Shenoy; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-09       Impact factor: 11.205

7.  β-Blockers have differential effects on the murine asthma phenotype.

Authors:  V J Thanawala; D J Valdez; R Joshi; G S Forkuo; S Parra; B J Knoll; M Bouvier; P Leff; R A Bond
Journal:  Br J Pharmacol       Date:  2015-10-13       Impact factor: 8.739

8.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

9.  Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma.

Authors:  Philip M Short; Peter A Williamson; William J Anderson; Brian J Lipworth
Journal:  Am J Respir Crit Care Med       Date:  2013-06-15       Impact factor: 21.405

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971
  10 in total
  1 in total

1.  Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al.

Authors:  Richard A Bond; Vaidehi J Thanawala; Sergio Parra; Paul Leff
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.